Soligenix invited to present at the cantor fitzgerald global healthcare conference

Princeton, n.j., sept. 27, 2021 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its president and chief executive officer, christopher j.

SNGX Ratings Summary

SNGX Quant Ranking